The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of Oregon on behalf of purchasers of Galena Biopharma, Inc. (NASDAQ:GALE) common stock during the period between May 9, 2013 and March 17, 2014, inclusive (the “Class Period”). Galena Biopharma Inc (NASDAQ:GALE) shares after opening at $2.44 moved to $2.49 on last trade day and at the end of the day closed at $2.45. Company price to sales ratio in past twelve months was calculated as 115.50 and price to cash ratio as 6.04. Galena Biopharma Inc (NASDAQ:GALE) showed a positive weekly performance of 6.99%.
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) announced that is has begun dosing study participants with ACH-3422, Achillion’s proprietary uridine-analog nucleotide inhibitor, in a Phase 1 clinical trial. ACH-3422 is being developed for use in combination regimens to treat chronic hepatitis C viral infection (HCV). Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) shares advanced 5.56% in last trading session and ended the day on $2.85. ACHN return on equity ratio is recorded as -34.20% and its return on assets is -32.00%. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) yearly performance is -62.20%.
Athersys, Inc. (NASDAQ:ATHX) announced interim results from the Phase 2 clinical study of the administration of Athersys’ MultiStem(R) cell therapy to treatment refractory ulcerative colitis (UC) patients being conducted by Pfizer, Inc. Athersys, Inc. (NASDAQ:ATHX) shares moved up 2.45% in last trading session and was closed at $1.47 while trading in range of $1.36 – $1.51 – Athersys, Inc. (NASDAQ:ATHX) year to date (YTD) performance is -41.40%.
Unwired Planet, Inc (NASDAQ:UPIP) announced that its wholly-owned subsidiary, Unwired Planet International Ltd., a company organized under the laws of the Republic of Ireland, has extended FRAND license offers to each defendant in its previously announced litigation in Germany and the United Kingdom. Unwired Planet Inc (NASDAQ:UPIP) weekly performance is 5.07%. On last trading day company shares ended up $2.28. Unwired Planet Inc (NASDAQ:UPIP) distance from 50-day simple moving average (SMA50) is 28.26%. Analysts mean target price for the company is $4.13.